43,736 Shares in National Health Investors, Inc. (NYSE:NHI) Purchased by Meritage Portfolio Management

Meritage Portfolio Management purchased a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 43,736 shares of the real estate investment trust's stock, valued at approximately $3,230,000. Meritage Portfolio Management owned approximately 0.09% of National Health Investors at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of NHI. TBH Global Asset Management LLC increased its position in National Health Investors by 9.9% in the 1st quarter. TBH Global Asset Management LLC now owns 17,297 shares of the real estate investment trust's stock valued at $1,278,000 after acquiring an additional 1,560 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of National Health Investors by 3.3% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust's stock worth $35,372,000 after acquiring an additional 15,497 shares during the period. Allspring Global Investments Holdings LLC increased its stake in National Health Investors by 15.8% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust's stock valued at $268,000 after purchasing an additional 495 shares in the last quarter. Woodmont Investment Counsel LLC purchased a new stake in National Health Investors during the first quarter worth $4,303,000. Finally, State of Alaska Department of Revenue boosted its position in National Health Investors by 5.9% during the first quarter. State of Alaska Department of Revenue now owns 21,230 shares of the real estate investment trust's stock worth $1,567,000 after purchasing an additional 1,190 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Price Performance

NHI stock traded down $0.37 on Monday, reaching $70.43. The company had a trading volume of 197,535 shares, compared to its average volume of 248,271. National Health Investors, Inc. has a 1 year low of $65.13 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 16.55 and a current ratio of 16.55. The company's fifty day moving average is $72.75 and its 200 day moving average is $71.62. The company has a market cap of $3.29 billion, a P/E ratio of 22.36, a PEG ratio of 4.27 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. The business had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. National Health Investors had a return on equity of 10.64% and a net margin of 41.15%. The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.10 EPS. On average, research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.60 annualized dividend and a dividend yield of 5.11%. National Health Investors's dividend payout ratio is presently 114.29%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Truist Financial upgraded National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 target price on the stock in a research report on Wednesday, July 2nd. Wedbush upgraded National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $85.75.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.